Shahir Kassam-Adams has joined the board of directors of OpenQ. Kassam-Adams is currently the Chief Strategy Officer of the Decision Resources Group. OpenQ is a provider of CRM biotech software, and has raised equity funding from investors including Grotech Ventures.
OpenQ is proud to announce the addition of Shahir Kassam-Adams to its board of directors. Mr. Kassam-Adams, currently the Chief Strategy Officer of the Decision Resources Group, brings a track record of success in executive management roles across the healthcare and information industries. His influence will be critical as OpenQ continues its rapid growth as a leader in helping global Life Science companies leverage the power of compliant medical networks.
“Shahir is a great addition to OpenQ’s Board of Directors,” said Chuck Cullen, OpenQ Board Member from Grotech Ventures. “Shahir brings a valuable strategic perspective from his work with cutting-edge data solutions. In addition, his experience and industry connections will serve as a tremendous asset for the Company as it continues its rapid growth trajectory.”
“I have been watching OpenQ for some time and am excited to join their team,” shared Shair Kassam-Adams. “This is a fantastic opportunity to work with an exciting company with a great set of solutions in a growing marketplace. I expect the marketplace will see some exciting new innovations in the coming year.”
“We are very glad to have Shahir on our board,” said Jim Zuffoletti, OpenQ’s President & Co-Founder. “His input will help guide us as we continue to expand globally and introduce innovate, new software and data products for the Life Sciences. He is a great fit with our business and we look forward to a long partnership.”
About Shahir Kassam-Addams
Shahir Kassam-Adams is Chief Strategy Officer for Decision Resources Group. Mr. Kassam-Adams joined the company in 2007 to lead strategy development and merger & acquisition activities across Decision Resources Group. Prior to joining Decision Resources Group, Mr. Kassam-Adams was the executive vice president for Thomson Reuters where his tenure included managing Thomson Reuters’ healthcare clinical decision support businesses and interim CEO for the scientific businesses with its Thomson Pharma offering. Mr. Kassam-Adams was also the Chief Strategy Officer for the Thomson Reuters’ $1.5B Scientific & Healthcare division and has prior general management experience in the information and publishing industry and significant executive management experience in the healthcare industry. Mr. Kassam-Adams received a Master of Business Administration from the Wharton School of the University of Pennsylvania, and a Master’s Degree in computer science from The Johns Hopkins University.
OpenQ helps life science companies harness the power of medical networks to compliantly and efficiently reach Key Opinion Leaders (KOLs) and Stakeholders. Their software and data solutions offer the industry-leading support for regulatory compliance that is needed for these critical, but high-risk relationships.
In its sixth year of rapid growth, OpenQ has a growing client list that spans the globe and includes 8 of the Top 10 pharmaceutical companies and 3 of the Top 5 medical device companies.
The continued interest of life sciences companies in OpenQ’s award-winning research and software products and their leading compliance solutions has led them to expand fourfold since 2003.